Abstract
An exciting recent development for high spatial resolution deep tissue imaging is long wavelength three-
photon fluorescence microscopy (3PM). Since its first demonstration of imaging subcortical structures in the
mouse brain, 3PM has driven rapid progress in deep tissue imaging beyond the depth limit of two-photon
fluorescence microscopy (2PM). Long-wavelength 3PM is perhaps the most promising new technology for deep
imaging within scattering biological tissues, and has potential impacts in a large number of biomedical fields such
as neuroscience, immunology, and cancer biology. On the other hand, there are a number of challenges that
must be overcome before 3PM can reach its full potential. Because it is a higher-order nonlinear process, three-
photon excitation (3PE) is inherently weaker than two-photon excitation (2PE). The weak signal strength of 3PM
is particularly problematic for fast imaging of dynamic cellular process. Furthermore, the laser sources for 3PM
are not yet optimized for deep tissue penetration, and the complexity and cost of the excitation source is a major
barrier for the applications of 3PM in a typical biomedical research lab. Finally, nearly all 3PM applications today
are in the brains. Reaching anatomical frontiers is equally possible in other organs with 3PM, but explicit
demonstrations of intravital imaging in novel locations are needed to bring deep imaging capability to other
biological systems. The research activity of this proposal will directly address the above challenges for in vivo
deep tissue 3PM. We will develop a new generation of 3PM that will improve the performance of existing 3PM
by two orders of magnitude and enable multi-color deep tissue imaging with a single excitation wavelength. We
will demonstrate the unprecedented imaging capabilities with a low-cost, fiber-based laser system, removing a
key barrier for the deployment of 3PM in biology labs. Furthermore, by applying our techniques to a wide variety
of biological systems, we will create a valuable knowledge base for the applications of 3PM. Our development
of the next generation 3PM parallels the development of 2PM, where the concerted development effort in lasers,
microscopes, and biological applications in the 1990s made 2PM ubiquitous in biomedical research labs by the
early 2000s. Our vision is to make deep, fast 3PM a routine instrument for a wide variety of biomedical
applications just as 2PM does in the shallower regions of biological tissues and organs. The successful
completion of this program will enable visualization of dynamic process at the sub-cellular level in intact organs
and animal models that are completely beyond the reach of any existing imaging techniques.
Public Health Relevance Statement
Narrative
Non-invasive optical imaging is essential for understanding biological functions at the cellular or sub-
cellular level. This project brings together an interdisciplinary team to develop the next generation microscopy
techniques for imaging deep and fast within intact tissues and organs.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
872612445
UEI
G56PUALJ3KT5
CCV3WG2JG248
D4H1NV4APKP3
ELS2M3C6V2S5
EQA8NBEN9WD5
FFAZGE9NH3M8
K6JRCJJXFET1
M8FBSLHASMT3
P4LRVQT1H4K5
PJUVN8AT5416
RT1JPM9UMGM5
ZBMGUAZYFGC4
ZMP8BDLJTUW9
Project Start Date
01-July-2022
Project End Date
31-March-2026
Budget Start Date
01-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$605,974
Direct Costs
$375,543
Indirect Costs
$230,431
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$605,974
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB033179-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB033179-03
Patents
No Patents information available for 5R01EB033179-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB033179-03
Clinical Studies
No Clinical Studies information available for 5R01EB033179-03
News and More
Related News Releases
No news release information available for 5R01EB033179-03
History
No Historical information available for 5R01EB033179-03
Similar Projects
No Similar Projects information available for 5R01EB033179-03